A study on efficacy of autonomic nerve regulating agents on manifestation of accessory pathway in paroxysmal supraventricular tachycardia patients
Not Applicable
- Conditions
- Paroxysmal supraventricular tachycardia (PSVT)
- Registration Number
- JPRN-UMIN000030753
- Lead Sponsor
- Hirosaki university hospital
- Brief Summary
Six patients showed fused atrial activation. Post-landiolol administration, the effective refractory period in AP stayed unchanged, while that of the AV node was prolonged. Wenckebach pacing rate via retrograde AV node decreased with landiolol, reducing the minimum ventricular pacing rate for atrial activation dissociation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
A)Patients who have allergy for landiolol. B)Patients who have contraindications for beta blocker (uncontrolled bronchial asthma, shock, coronary spastic angina, peripheral artery disease). C)Patients with heart rate of 40 times/min or less D)Patients with low left ventricular function (left ventricular ejection fraction: 25% or less). E)Patients who are not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effective refractory period of and conduction time of accessory pathway.
- Secondary Outcome Measures
Name Time Method